Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment
Yu Zhang(Kunming University of Science and Technology), Joshua D. Milner(National Institute of Allergy and Infectious Diseases), Mie Ichikawa(Sanford Burnham Prebys Medical Discovery Institute), Ian T. Lamborn(National Institute of Allergy and Infectious Diseases), Emily S. Kim(National Institutes of Health), Joshua McElwee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Helen C. Su(National Institute of Allergy and Infectious Diseases), Hudson H. Freeze(Discovery Institute), Jonathan J. Lyons(University of California San Diego), Daniel S. Reich(National Institutes of Health), Huie Jing(Office of Extramural Research), Sarah M. Kranick(National Institutes of Health), Matthew Biancalana(National Institutes of Health), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Alexandra F. Freeman(National Institutes of Health), Lynne A. Wolfe(National Institutes of Health), Shrimati Datta(National Institute of Allergy and Infectious Diseases), Xiaomin Yu(Wenzhou Medical University), Huseyin Mehmet(Merck & Co., Inc., Rahway, NJ, USA (United States)), Helen Matthews(National Institutes of Health), Jason D. Hughes(University of California, Irvine), Kelly D. Stone(National Institutes of Health), Thomas DiMaggio(National Institutes of Health)
Cited by 248
Related Papers
Essentials of Glycobiology
|Unknown|1999|2.5k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k